Pricing & Access· May 27, 2026 · 10 min read
Spravato REMS and coverage guide for esketamine access
By Ran Chen#REMS#Prior Authorization#Coverage Access
Topic
NMDA
NMDA-targeted therapies, CNS evidence, coverage criteria, REMS friction, and access workflows.